here
Access campaignStatements and Opinions
Switzerland
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
February 15, 2024 | IndiaSwitzerland
Access campaignStatements and Opinions
Switzerland
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as...
February 14, 2024 | IndiaSwitzerland
Access campaignPress release
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
November 15, 2023 | France
Access campaignPress release
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023 |
Access campaign
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins...
November 7, 2023 | Switzerland
Access campaignPress release
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key...
September 30, 2023 |
Press release
MSF: TB test price reduction by Cepheid and Danaher is an important step in the...
September 19, 2023 |
Access campaign
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to...
September 12, 2023 |
Press release
MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies
August 17, 2023 | India
Press release
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
July 25, 2023 | Mozambique
Press release
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug...
July 18, 2023 |